Merck Singulair Presents Managed Care Test: Covering Asthma, Not Allergies
Executive Summary
Merck's Singulair approval in allergic rhinitis presents a challenge for managed care to differentiate between the drug's existing asthma indication and its use in allergies when making coverage decisions
You may also be interested in...
Aventis Sees “Blurring” Of Rx/OTC Distinctions; Change Coming For Allegra?
The antihistamine market can no longer comfortably be divided between prescription and OTC entrants, Aventis Chief Operating Officer Richard Markham suggested during the J.P. Morgan health care conference in San Francisco Jan. 13
Aventis Sees “Blurring” Of Rx/OTC Distinctions; Change Coming For Allegra?
The antihistamine market can no longer comfortably be divided between prescription and OTC entrants, Aventis Chief Operating Officer Richard Markham suggested during the J.P. Morgan health care conference in San Francisco Jan. 13
Aetna Sees 80% Decrease In Rx Non-Sedating Antihistamine Use Post-Claritin
Aetna's aggressive formulary management steps following the OTC switch of Claritin have led to an 80% decrease in use of prescription non-sedating antihistamines by members, the insurer says